You have to be signed in to use this resource.
Clinical Significance of Blood Group Antibodies
This document outlines current knowledge on the clinical significance of blood group alloantibodies. Its prime purpose is to enable clinical decisions to be made regarding the management and blood transfusion support of patients with blood group antibodies that are not commonly encountered and for which antigen-negative blood may not be available in the routine stock. The overall aim is to ensure that a uniform RCI Clinical Policy for the supply of blood for transfusion is implemented throughout NHSBT.
Resource details
| Contributed by: | Pathology Portal |
| Authored by: |
|
| Licence: | More information on licences |
| Last updated: | 02 January 2024 |
| First contributed: | 09 December 2023 |
| Audience access level: | Full user |
Share this resource
Report an issue with this resource
You may report a resource, for example, if there is an issue with copyright infringement, breach of personal data, factual inaccuracies, typing errors or safety concerns. The type of issue will determine whether the resource is immediately removed from the platform or if the contributor is asked to make amendments. You can report a resource from the resource information page or by contacting the Learning Hub support team.
You can contact the Learning Hub support team by completing the support form or if you have a general enquiry you can email enquiries@learninghub.nhs.uk.